Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. H. Lin, C. M. Weng, B. C. Chen, M. L. Kuo (Taipei, Taiwan). Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway. Eur Respir J 2013; 42: Suppl. 57, 4890

Member's Comments

No comment yet.

Related content which might interest you: B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Connective tissue disease-related interstitial lung disease and lung cancer Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF Source: Eur Respir J 2001; 17: 1220-1227 Year: 2001 Regulation of connective tissue growth factor gene by lipopolysaccharide in bronchial epithelial cells Source: Eur Respir J 2005; 26: Suppl. 49, 556s Year: 2005 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014 Serine and arginine-rich splicing factors as nuclear targets for TGF-beta1 Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Human lung scaffolds to model lung disease and tissue regeneration Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018 Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 The effects of tobramycin on pulmonary fibroblast function Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Connective tissue growth factor (CTGF) induces lung fibrosis in otherwise fibrosis-resistant Balb/c mouse in a bleomycin model Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014